grantlife_8k-060408.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of
Report (Date of Earliest Event
Reported):
June 4,
2008
Grant
Life Sciences, Inc.
(Exact
name of registrant as specified in its charter)
Nevada
|
|
000-50133
|
|
82-0490737
|
(State
or other jurisdiction
|
|
(Commission
|
|
(I.R.S.
Employer
|
of
incorporation)
|
|
File
Number)
|
|
Identification
No.)
|
|
|
|
|
|
1787
East Ft. Union Blvd., Suite 202
Salt
Lake City, Utah
|
|
|
|
84121
|
(Address
of principal executive offices)
|
|
|
|
(Zip
Code)
|
|
|
|
Registrant’s
telephone number, including area code:
|
|
(801)
733-0878
|
Copies
to:
Gregory
Sichenzia, Esq.
Sichenzia
Ross Friedman Ference LLP
61
Broadway, 32nd
Floor
Phone:
(212) 930-9700
Fax:
(212) 930-9725
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o Written communications pursuant
to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to
Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
5.03 Amendments to
Articles of Incorporation or Bylaws; Change in Fiscal Year.
On June
4, 2008, Grant Life Sciences, Inc. (the “Company”) filed a Certificate of
Designation (the “Certificate of Designation”) establishing the Voting Powers,
Designations, Preferences, Limitations, Restrictions, and Relative Rights of
Series A Convertible Preferred Stock (“Preferred Stock”) such that the number of
shares constituting the Preferred Stock shall be 4,000,000. Holders
of Preferred Stock shall be entitled to vote on all matters submitted to
shareholders of the Company and shall be entitled to one hundred and fifty votes
for each share of Preferred Stock owned at the determined record
date. Subject to the terms of the Certificate of Designation, each
share of Preferred Stock is convertible into ten shares of the Company’s Common
Stock.
A copy of
the Certificate of Designation is attached as Exhibit 3.1 to this Form 8-K and
is incorporated herein by reference.
ITEM
9.01 Financial Statements
and Exhibits
Exhibit
Number
|
|
Description
|
3.1
|
|
Certificate
of Designation for Series A Convertible Preferred
Stock
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
Grant
Life Sciences, Inc. |
|
|
|
|
|
Date:
June 6, 2008
|
By:
|
/s/ Hun
Chi-Lin |
|
|
|
Name:
Hun Chi-Lin |
|
|
|
Title:
President |
|
|
|
|
|